ÅǸ޴º
Á¦¸ñ | Kim MN (1ÀúÀÚ, ±³½ÅÀúÀÚ), Lee SM, Kim JS, Hwang SG. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2019 Oct;84(4):809-817. | µî·ÏÀÏ | 20191017 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Kim MN (1ÀúÀÚ, ±³½ÅÀúÀÚ), Lee SM, Kim JS, Hwang SG. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2019 Oct;84(4):809-817.
|
Copyright ¨Ï chamc, All rights reserved.